Skip to main content

Peer Review reports

From: Adjuvant chemotherapy could not bring survival benefit to HR-positive, HER2-negative, pT1b-c/N0–1/M0 invasive lobular carcinoma of the breast: a propensity score matching study based on SEER database

Original Submission
16 Sep 2019 Submitted Original manuscript
21 Sep 2019 Author responded Author comments - guangfu hu
Resubmission - Version 2
21 Sep 2019 Submitted Manuscript version 2
26 Nov 2019 Reviewed Reviewer Report - Megan Kruse
27 Nov 2019 Reviewed Reviewer Report - Alexandre de Nonneville
23 Dec 2019 Author responded Author comments - guangfu hu
Resubmission - Version 3
23 Dec 2019 Submitted Manuscript version 3
1 Feb 2020 Author responded Author comments - guangfu hu
Resubmission - Version 4
1 Feb 2020 Submitted Manuscript version 4
Publishing
7 Feb 2020 Editorially accepted
21 Feb 2020 Article published 10.1186/s12885-020-6614-0

You can find further information about peer review here.

Back to article page